Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $4,494.00 |
|---|---|
| Enterprise Value | $-1,997,148.00 |
| Earnings per Share | $-0.7 |
| Beta | 5.25 |
| Outstanding Shares | 22,470,000 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | -19.04 |
| Enterprise Value to EBIT | 0.41 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.95 |
| Debt to Equity | 0.57 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily engaged in creating modified botanical Schedule 1 molecules for use within the United States. The firm's pipeline encompasses five entirely synthetic, proprieta...